Delivery Order SPE2DB24D9144-SPE2DB24FCMKZ

Award Date 9/5/24
Potential Completion Date 9/26/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $20,866.56 contract was awarded by the Defense Logistics Agency (DLA) on August 19, 2024 and has an ultimate completion date of September 10, 2024. The award is for the delivery of 1,000 unit vials of the pharmaceutical product Kcentra. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up...
This is a firm fixed-price delivery order worth $22,800.00 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the biologic drug Kcentra by February 26, 2024. This delivery order falls under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $78,466.75 contract is for the delivery of 1,000 unit vials of the pharmaceutical product Kcentra. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which enables the DLA to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the pharmaceutical product KCENTRA, with a ceiling value of $12,743.68 and a period of performance through May 6, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) for the supply of Kcentra 1,000 unit vials. The order, valued at $17,312.80, is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA for the provision of a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DX program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $29,630.88 award is for the supply of 1,000 units of the blood-clotting drug Kcentra to support the recurring pharmaceutical needs of military health facilities. The contract has an ultimate completion date of August 5, 2024. This delivery order is part of a...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,448.32 contract is for the delivery of 1,000 unit vials of the specialized pharmaceutical product Kcentra. The contract is not associated with any set-aside designation and has an ultimate completion date of January 14, 2025. DMS Pharmaceutical Group holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,961.04 contract is for the delivery of 500-unit vials of the medication Kcentra. The award is not associated with a set-aside designation. However, DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 1,000 unit vials of the pharmaceutical product Kcentra, a blood clotting medication. The contract has a ceiling value of $9,557.76 and an ultimate completion date of December 21, 2023. DMS Pharmaceutical Group Inc. holds a larger $499,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 1,000 unit vials of the drug Kcentra, valued at $6,639.36. The contract is a firm fixed-price delivery order with an ultimate completion date of April 3, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB24FCMKZ
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $1,732.80 and has an ultimate completion date of September 26, 2024. The contract is for the delivery of Kcentra 500 unit vials, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide.

This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, from common medications to specialized drugs and medical supplies, to fulfill the diverse medical requirements of the Department of Defense (DoD) healthcare facilities. The contract does not have a set-aside designation.

Generated 12/5/24, 10:42 AM